To
deliver membrane-impermeable drugs into eukaryotic
cells, a
lot of cell-penetrating peptides (CPPs) were discovered. Previously
we designed an amphipathic α-helical peptide which dimerizes
itself via its two C-residues. This bis-disulfide-linked
dimeric bundle, LK-3, has remarkable cell-penetrating ability at nanomolar
concentration, which is an essential prerequisite for CPP. In an effort
to optimize the sequence of LK-3, we adjusted its length and evaluated
changes in the dimerization rate. We found that a 10-amino-acid monomer
has the fastest dimerization rate and subsequently modified its hydrophobic
and hydrophilic residues to construct a small peptide library. The
evaluation of cell permeability of these derivatives showed that their
cell-penetrating ability is comparable to that of the LK-3, except
V- or H-containing ones. In this library, diLR10 was found to display
fast nanomolar cell membrane penetration, low toxicity, and ease of
production. The methotrexate (MTX) conjugate of diLR10, MTX-diLR10,
has a 19-fold increased efficacy over MTX in MDA-MB-231 cells and
efficiently deflates lesions in a rheumatoid arthritis (RA) in vivo mouse model.